Death ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Acetaminophen plus Diphenhydramine led to lower death ‐ not reported compared with placebo; GRADE not reported.
1 finding from 1 review
Death ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Acetaminophen plus Diphenhydrammine led to lower death ‐ not reported compared with placebo (Unit of randomisation: transfusion); GRADE not reported.
1 finding from 1 review
Adverse events: death · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: death compared with oral steroids alone (low certainty).
1 finding from 1 review
Adverse events: death · idiopathic steroid‐resistant nephrotic syndrome in children
Calcineurin inhibitor showed no clear difference in adverse events: death compared with IV cyclophosphamide (low certainty).
1 finding from 1 review
Intervention not reported
Death from all causes · HIV‐negative people with tuberculous pericarditis
The intervention showed no clear difference in death from all causes (low certainty).
1 finding from 1 review
Intervention not reported
Death from all causes · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
It is very uncertain whether the intervention changes death from all causes (very low certainty).
1 finding from 1 review
Adverse events (death) · people with diabetes and foot ulcers
It is very uncertain whether oral nutritional supplement with 20 g protein per 200 mL bottle, 1… changes adverse events (death) compared with placebo (very low certainty).
1 finding from 1 review
All cardiovascular death · heart failure with chronic kidney disease
CHRONIC: ACEi or ARB showed no clear difference in cardiovascular death ( compared with placebo (low certainty).
1 finding from 1 review
All cardiovascular death · heart failure with chronic kidney disease
CHRONIC: Beta‐blockers may leads to lower cardiovascular death ( compared with placebo (low certainty).
1 finding from 1 review
Adverse events ‐ death · adults with common mental disorders
It is very uncertain whether primary‐level worker‐led collaborative care changes adverse events ‐ death compared with usual care (very low certainty).
1 finding from 1 review
Intervention not reported
Death from pericarditis · HIV‐negative people with tuberculous pericarditis
The intervention probably leads to lower death from pericarditis (moderate certainty).
1 finding from 1 review
Intervention not reported
Death from pericarditis · HIV‐positive people with tuberculous pericarditis. Most patients (80%) not on antiretroviral drugs
It is very uncertain whether the intervention changes death from pericarditis (very low certainty).
1 finding from 1 review
Death: unknown time frame · CRRT
It is very uncertain whether unfractionated heparin changes death: unknown time frame compared with low molecular weight heparin (very low certainty).
1 finding from 1 review
Death (any cause) (median · people with ESKD
Counselling showed no clear difference in death (any cause) (median compared with usual care (low certainty).
1 finding from 1 review
Death (any cause) (median · people with ESKD
Cognitive‐behavioural therapy showed no clear difference in death (any cause) (median compared with usual care (low certainty).
1 finding from 1 review
Perinatal mortality · Pregnant women with hyperemesis gravidarum
Acupuncture showed no clear difference in stillbirth and neonatal death compared with placebo (low certainty).
1 finding from 1 review
Perinatal mortality · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in stillbirth and neonatal death compared with promethazine (low certainty).
1 finding from 1 review
Perinatal mortality · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes stillbirth and neonatal death compared with placebo (very low certainty).
1 finding from 1 review
CKD or death: death by 52 weeks · idiopathic steroid‐resistant nephrotic syndrome in children
Cyclosporin showed no clear difference in CKD or death: death by 52 weeks compared with mycophenolate mofetil with pulse dexamethasone (low certainty).
1 finding from 1 review
Cardiac mortality · patients with coronary heart disease
Work‐directed counselling showed no clear difference in adverse effects: cardiac deaths compared with usual care (moderate certainty).
1 finding from 1 review